Overview
News
October 1, 2008
Venous Blood Clot Prevention after Elective Hip or Knee Replacement Surgery:
Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care » more
Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care » more
1:48 min.
1:07 min. September 30, 2008
Pre-Clinical Cancer Research:
Bayer starts new research cooperation in Asia
Research collaboration with National University of Singapore signed / Further collaborations planned / Overall investment volume of 10 million Euro » more
Bayer starts new research cooperation in Asia
Research collaboration with National University of Singapore signed / Further collaborations planned / Overall investment volume of 10 million Euro » more
September 25, 2008
Bayer Schering Pharma AG
Squeeze-out entered in the Commercial Register
Squeeze-out of minority stockholders takes effect / Cash compensation of EUR 98.98 per share will be paid » more
Squeeze-out entered in the Commercial Register
Squeeze-out of minority stockholders takes effect / Cash compensation of EUR 98.98 per share will be paid » more
5:47 min.
Bookmark this page
E-mail this page
Bayer Websites Worldwide
